Genetic polymorphisms predict response to anti-tumor necrosis factor treatment in Crohn’s disease

AIM: To investigate genetic factors that might help define which Crohn’s disease (CD) patients are likely to benefit from anti-tumor necrosis factor (TNF) therapy. METHODS: This was a prospective cohort study. Patients were recruited from a university digestive disease practice database. We included...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:World J Gastroenterol
Glavni autori: Netz, Uri, Carter, Jane Victoria, Eichenberger, Maurice Robert, Dryden, Gerald Wayne, Pan, Jianmin, Rai, Shesh Nath, Galandiuk, Susan
Format: Artigo
Jezik:Inglês
Izdano: Baishideng Publishing Group Inc 2017
Teme:
Prospective Study
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5526766/
https://ncbi.nlm.nih.gov/pubmed/28785150
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v23.i27.4958
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items